ERG is a megakaryocytic oncogene
- PMID: 19487285
- DOI: 10.1158/0008-5472.CAN-09-0075
ERG is a megakaryocytic oncogene
Abstract
Ets-related gene (ERG) is a member of the ETS transcription factor gene family located on Hsa21. ERG is known to have a crucial role in establishing definitive hematopoiesis and is required for normal megakaryopoiesis. Truncated forms of ERG are associated with multiple cancers such as Ewing's sarcoma, prostate cancer, and leukemia as part of oncogenic fusion translocations. Increased expression of ERG is highly indicative of poor prognosis in acute myeloid leukemia and ERG is expressed in acute megakaryoblastic leukemia (AMKL); however, it is unclear if expression of ERG per se has a leukemogenic activity. We show that ectopic expression of ERG in fetal hematopoietic progenitors promotes megakaryopoiesis and that ERG alone acts as a potent oncogene in vivo leading to rapid onset of leukemia in mice. We observe that the endogenous ERG is required for the proliferation and maintenance of AMKL cell lines. ERG also strongly cooperates with the GATA1s mutated protein, found in Down syndrome AMKL, to immortalize megakaryocyte progenitors, suggesting that the additional copy of ERG in trisomy 21 may have a role in Down syndrome AMKL. These data suggest that ERG is a hematopoietic oncogene that may play a direct role in myeloid leukemia pathogenesis.
Similar articles
-
ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.Blood. 2009 Apr 2;113(14):3337-47. doi: 10.1182/blood-2008-08-174813. Epub 2009 Jan 23. Blood. 2009. PMID: 19168790 Free PMC article.
-
The proto-oncogene ERG in megakaryoblastic leukemias.Cancer Res. 2005 Sep 1;65(17):7596-602. doi: 10.1158/0008-5472.CAN-05-0147. Cancer Res. 2005. PMID: 16140924
-
The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells.Nat Immunol. 2008 Jul;9(7):810-9. doi: 10.1038/ni.1617. Epub 2008 May 25. Nat Immunol. 2008. PMID: 18500345
-
Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.Early Hum Dev. 2006 Dec;82(12):767-73. doi: 10.1016/j.earlhumdev.2006.09.016. Epub 2006 Oct 24. Early Hum Dev. 2006. PMID: 17064858 Review.
-
Acute myeloid leukemia: a central role for the ETS factor ERG.Int J Biochem Cell Biol. 2011 Oct;43(10):1413-6. doi: 10.1016/j.biocel.2011.05.014. Epub 2011 Jun 1. Int J Biochem Cell Biol. 2011. PMID: 21664289 Review.
Cited by
-
Tumorigenesis in Down's syndrome: big lessons from a small chromosome.Nat Rev Cancer. 2012 Oct;12(10):721-32. doi: 10.1038/nrc3355. Epub 2012 Sep 21. Nat Rev Cancer. 2012. PMID: 22996602
-
Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome.Blood. 2010 Apr 8;115(14):2928-37. doi: 10.1182/blood-2009-06-227629. Epub 2010 Feb 12. Blood. 2010. PMID: 20154221 Free PMC article.
-
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG.Nat Commun. 2023 Sep 21;14(1):5871. doi: 10.1038/s41467-023-41067-2. Nat Commun. 2023. PMID: 37735473 Free PMC article.
-
Clinical and biological aspects of myeloid leukemia in Down syndrome.Leukemia. 2021 Dec;35(12):3352-3360. doi: 10.1038/s41375-021-01414-y. Epub 2021 Sep 13. Leukemia. 2021. PMID: 34518645 Free PMC article. Review.
-
Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder.Blood. 2013 Aug 8;122(6):988-98. doi: 10.1182/blood-2012-10-460998. Epub 2013 May 29. Blood. 2013. PMID: 23719302 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources